ABSI Absci Corporation Common Stock Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
14:06
Aug 30
Avalon Purnell Bloomberg Markets
Bloomberg Markets
Six-month injectable offers biggest differentiation.
Abzai has potentially the most differentiated product in the space: a long-acting injection given roughly every six months to maintain hair, supported by the GLP-1 precedent that consumers are now willing to take shots.
ABSI Absci Corporation Common Stock Long 1ST — —
10:44
Jun 18
CryptoCondom
Buy ABSI as a play on AI-augmented biotech/digital biology convergence.
Buy ABSI as a play on AI-augmented biotech/digital biology convergence; author frames this as a high-regret-risk omission for portfolios lacking exposure to the trend.
ABSI Absci Corporation Common Stock Long — —
00:56
Jun 02
CryptoCondom
Author explicitly says ABSI, ABCL, and IOVA are their bets on the digital biology narrative.
Author explicitly says ABSI, ABCL, and IOVA are their bets on the digital biology narrative, which they expects to run hard.
ABSI Absci Corporation Common Stock Long — —
Log in to see ideas

About ABSI Investor Commentary

Across the available history and selected sources, Buzzberg tracks ABSI (Absci Corporation Common Stock) across 5 sources: 14 bullish vs 0 bearish calls from 6 authors. Historical directional balance: 56% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 25 total trade ideas tracked. Latest voices: Avalon Purnell, CryptoCondom.